FDA approves new coronavirus antigen test with fast results
Antigen tests can diagnose active infections by detecting the earliest toxic traces of the virus rather than genetic code of the virus itself.
Watch CBS News
Antigen tests can diagnose active infections by detecting the earliest toxic traces of the virus rather than genetic code of the virus itself.
The FDA says he tested negative for COVID-19.
Having the coronavirus antibodies is only one piece of the puzzle.
Swiss biotech firm says its blood test is 100% accurate in detecting the presence of coronavirus antibodies.
While the New York tri-state region is experiencing a drop in coronavirus cases and hospitalizations, Gottlieb said the number of cases is rising daily in about 20 other states.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, May 3, 2020, on "Face the Nation."
TV host says FDA guidelines currently prevent him from donating blood plasma, which may contain antibodies helpful in finding a COVID-19 vaccine.
Gottlieb said on "Face the Nation" that Georgia's reopening increases the risk of infection and said the state is "certainly not out of the woods."
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, April 26, 2020, on "Face the Nation."
President Trump gave an unusually short coronavirus task force briefing on Friday, walking out after less than half an hour. Earlier in the day, Mr. Trump walked back his Thursday suggestion that people could inject disinfectant to fight the coronavirus, a claim that horrified medical experts and he now says was only "sarcastic." The FDA also issued warnings on hydroxychloroquine, a malaria drug Mr. Trump has previously touted as a treatment. Nikole Killion reports on the latest from the White House.
The president called it a "game changer." Now the FDA says it has "not been shown to be safe."
The United States is currently doing below 200,000 new coronavirus tests per day, according to COVID Tracking Project.
The test kit costs $119 and is expected to be available for consumers in most states within weeks.
High demand has spawned dozens of tests onto the market and the FDA is being criticized for favoring speed over accuracy, allowing too many to be sold without regulation.
Gottlieb said on "Face the Nation" that people "still need to be worried" about the Southeast and Sun Belt.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, April 19, 2020, on "Face the Nation."
Dr. Scott Gottlieb warned there could be a big risk in the fall when schools reopen.
"China was not truthful with the world at the outset of this," Gottlieb said on "Face the Nation."
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, April 12, 2020, on "Face the Nation."
Gottlieb said the nation needs a "better toolbox" and "good medicine cabinet," along with surveillance, to better address future coronavirus outbreaks.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, April 5, 2020, on "Face the Nation."
The FDA said the changes are "expected to remain in place" after the coronavirus pandemic has subsided.
FDA orders drugmakers to pull popular heartburn medications that contain trace amounts of a carcinogen.
Gottlieb seemed to split from President Trump, who wants to reopen the U.S. economy, as early as April 12, and said it's "too early" to lift restrictions.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, March 29, 2020, on "Face the Nation."